George Agelis
About
George Agelis is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics.
According to data from OpenAlex, George Agelis has authored 27 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 13 papers in Organic Chemistry and 4 papers in Computational Theory and Mathematics. Recurrent topics in George Agelis's work include Chemical Synthesis and Analysis (8 papers), Carbohydrate Chemistry and Synthesis (7 papers) and Receptor Mechanisms and Signaling (6 papers). George Agelis is often cited by papers focused on Chemical Synthesis and Analysis (8 papers), Carbohydrate Chemistry and Synthesis (7 papers) and Receptor Mechanisms and Signaling (6 papers). George Agelis collaborates with scholars based in Greece, Canada and Slovenia. George Agelis's co-authors include John Matsoukas, Dimitri Komiotis, Avrelija Čenčič, Tanja Botić, Thomas Mavromoustakos, Stella Manta, Serdar Durdağı, Demetrios Vlahakos, Qiao Wu and Theodore Tselios and has published in prestigious journals such as Journal of Medicinal Chemistry, Molecules and European Journal of Medicinal Chemistry.
In The Last Decade
George Agelis
27 papers receiving 451 citations
Peers
George Agelis
Robert G. Gentles United States
Anja Sandström Sweden
John W. Butcher United States
Aloysius T. Nchinda South Africa
Elizabeth M. Moir United Kingdom
Douglas C. Beshore United States
Oreste Livi Italy
John P. Caldwell United States
Isabella Fiorini Italy
Marco F. Schmidt Germany
Citations per year, relative to George Agelis George Agelis (= 1×)
peers
Robert G. Gentles
Countries citing papers authored by George Agelis
Since
Specialization
Citations
This map shows the geographic impact of George Agelis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Agelis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Agelis more than expected).
Fields of papers citing papers by George Agelis
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by George Agelis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Agelis. The network helps show where George Agelis may publish in the future.
Co-authorship network of co-authors of George Agelis
This figure shows the co-authorship network connecting the top 25 collaborators of George Agelis. A scholar is included among the top collaborators of George Agelis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Agelis. George Agelis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Vlahakos, Demetrios, George Agelis, Anthony Zulli, et al.. (2018). Transdermal Delivery of AT1 Receptor Antagonists Reduce Blood Pressure and Reveal a Vasodilatory Effect on Kidney Blood Vessels. Current Molecular Pharmacology. 11(3). 226–236.
2.
Ntountaniotis, Dimitrios, George Agelis, Maria Halabalaki, et al.. (2014). An Efficient Synthetic Method and Theoretical Calculations of Olmesartan Methyl Ether: Study of Biological Function of AT1 Antagonism. Combinatorial Chemistry & High Throughput Screening. 17(8). 652–662.
3.
Mavromoustakos, Thomas, George Agelis, & Serdar Durdağı. (2013). AT1 antagonists: a patent review (2008 – 2012). Expert Opinion on Therapeutic Patents. 23(11). 1483–1494.
4.
Agelis, George, Catherine Koukoulitsa, Jiřina Slaninová, et al.. (2013). Rational design, efficient syntheses and biological evaluation of N , N ′-symmetrically bis-substituted butylimidazole analogs as a new class of potent Angiotensin II receptor blockers. European Journal of Medicinal Chemistry. 62. 352–370.
5.
Agelis, George, Konstantinos Kelaidonis, Dimitra Kalavrizioti, et al.. (2013). Facile and Efficient Syntheses of a Series of N-Benzyl and N-Biphenylmethyl Substituted Imidazole Derivatives Based on (E)-Urocanic acid, as Angiotensin II AT1 Receptor Blockers. Molecules. 18(7). 7510–7532.
6.
Agelis, George, Serdar Durdağı, Jiřina Slaninová, et al.. (2012). The discovery of new potent non-peptide Angiotensin II AT1 receptor blockers: A concise synthesis, molecular docking studies and biological evaluation of N-substituted 5-butylimidazole derivatives. European Journal of Medicinal Chemistry. 55. 358–374.
7.
Agelis, George, Minos–Timotheos Matsoukas, Theodore Tselios, et al.. (2010). Towards non-peptide ANG II AT1 receptor antagonists based on urocanic acid: rational design, synthesis and biological evaluation. Amino Acids. 40(2). 411–420.
8.
Agelis, George, Serdar Durdağı, Konstantinos Kelaidonis, et al.. (2010). An efficient synthesis of a rationally designed 1,5 disubstituted imidazole AT1 Angiotensin II receptor antagonist: reorientation of imidazole pharmacophore groups in losartan reserves high receptor affinity and confirms docking studies. Journal of Computer-Aided Molecular Design. 24(9). 749–758.
9.
Saifeddine, Mahmoud, et al.. (2009). Design, synthesis and biological evaluation of non-peptide PAR1 thrombin receptor antagonists based on small bifunctional templates: arginine and phenylalanine side chain groups are keys for receptor activity. Amino Acids. 38(4). 985–990.
10.
Manta, Stella, et al.. (2008). A concise synthesis of 3-fluoro-5-thio-xylo- and glucopyranoses, useful precursors towards their corresponding pyranonucleoside derivatives. Carbohydrate Research. 343(6). 1099–1103.
11.
Agelis, George, et al.. (2007). Exomethylene pyranonucleosides: Efficient synthesis and biological evaluation of 1-(2,3,4-trideoxy-2-methylene-β-d-glycero-hex-3-enopyranosyl)thymine. Bioorganic & Medicinal Chemistry. 15(16). 5448–5456.
12.
Agelis, George, et al.. (2007). An efficient synthesis of 3-fluoro-5-thio-xylofuranosyl nucleosides of thymine, uracil, and 5-fluorouracil as potential antitumor or/and antiviral agents. Bioorganic & Medicinal Chemistry. 15(9). 3241–3247.
13.
Manta, Stella, George Agelis, Tanja Botić, Avrelija Čenčič, & Dimitri Komiotis. (2007). Unsaturated fluoro-ketopyranosyl nucleosides: Synthesis and biological evaluation of 3-fluoro-4-keto-β-d-glucopyranosyl derivatives of N4-benzoyl cytosine and N6-benzoyl adenine. European Journal of Medicinal Chemistry. 43(2). 420–428.
14.
Agelis, George, et al.. (2007). Synthesis and molecular modelling of unsaturated exomethylene pyranonucleoside analogues with antitumor and antiviral activities. European Journal of Medicinal Chemistry. 43(7). 1366–1375.
15.
Manta, Stella, George Agelis, Tanja Botić, Avrelija Čenčič, & Dimitri Komiotis. (2006). Fluoro-ketopyranosyl nucleosides: Synthesis and biological evaluation of 3-fluoro-2-keto-β-d-glucopyranosyl derivatives of N4-benzoyl cytosine. Bioorganic & Medicinal Chemistry. 15(2). 980–987.
16.
Matsoukas, John, George Agelis, Amal Wahhab, et al.. (1995). Differences in Backbone Structure between Angiotensin II Agonists and Type I Antagonists. Journal of Medicinal Chemistry. 38(23). 4660–4669.
17.
Moore, Graham J., et al.. (1994). Receptor interactions of the position 4 side chains of angiotensin II analogues: Importance of aromatic ring quadrupole. Journal of Molecular Recognition. 7(4). 251–256.
18.
Matsoukas, John, et al.. (1994). Novel Synthesis of Cyclic Amide-Linked Analogs of Angiotensins II and III. Journal of Medicinal Chemistry. 37(18). 2958–2969.
19.
Matsoukas, John, et al.. (1993). Synthesis and biological activities of angiotensin II, sarilesin, and sarmesin analogs containing Aze or Pip at position 7. Journal of Medicinal Chemistry. 36(7). 904–911.
20.
Lonergan, Greg, et al.. (1992). Isolation, Nmr Studies, and Biological Activities of Onopordopicrin from Centaurea sonchifolia. Journal of Natural Products. 55(2). 225–228.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Robert G. Gentles Breakdown of academic impact, for papers by Anja Sandström Breakdown of academic impact, for papers by John W. Butcher Breakdown of academic impact, for papers by Aloysius T. Nchinda Breakdown of academic impact, for papers by Elizabeth M. Moir Breakdown of academic impact, for papers by Douglas C. Beshore Breakdown of academic impact, for papers by Oreste Livi Breakdown of academic impact, for papers by John P. Caldwell Breakdown of academic impact, for papers by Isabella Fiorini Breakdown of academic impact, for papers by Marco F. Schmidt